Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Modified Draize Repeat Insult Patch Test in Healthy Volunteers, of Either Sex, to Investigate the Irritation and Allergenic Potential of One Test Article Following Repeated Cutaneous Patch Applications

NCT06810856 is registered in ClinicalTrials.gov with Repolar Pharmaceuticals Oy as lead sponsor.

NCT NCT06810856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06810856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Modified Draize Repeat Insult Patch Test in Healthy Volunteers, of Either Sex, to Investigate the Irritation and Allergenic Potential of One Test Article Following Repeated Cutaneous Patch Applications
Lead sponsor
Repolar Pharmaceuticals Oy
Phase
Not applicable
Overall status
Completed
Start date
October 16, 2019
Completion date
October 25, 2019
Enrollment
215 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skin irritation, skin sensitization